Cerebral vs GE HealthCare
Side-by-side comparison of AI visibility scores, market position, and capabilities
Online mental health platform for therapy, medication management, and psychiatry, San Francisco CA, raised $300M+. Serves anxiety, depression, ADHD, and insomnia.
About
Cerebral is a San Francisco, California-based online mental health company founded in 2020 that offers therapy, psychiatric evaluations, and medication management through a telehealth platform. The company raised over $300 million, achieving unicorn status in 2021 during a period of rapid growth, and serves patients with conditions including anxiety, depression, ADHD, insomnia, and bipolar disorder through a subscription-based access model.\n\nCerebral's model is designed to make psychiatric care and therapy more accessible than traditional in-person services by offering online intake, same-week appointments with licensed clinicians, electronic prescriptions, and medication delivery through pharmacy partners. The platform serves both self-pay and insurance-covered patients, having expanded insurance contracting significantly to reduce cost barriers. Cerebral employs a large clinician workforce of therapists and psychiatric nurse practitioners operating across most US states.\n\nThe company navigated a period of regulatory and reputational scrutiny in 2022–2023 related to prescribing practices and marketing claims, which led to leadership changes, workforce restructuring, and a strategic refocus on clinical quality and compliance. Cerebral has since invested in clinical governance infrastructure, stricter prescribing protocols, and transparent outcomes reporting. The company continues to compete with Talkspace, Done, and Done Global in the online psychiatry and therapy market, and has repositioned around a more clinically rigorous, insurance-first approach following the operational challenges of its hypergrowth phase.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
About
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.